All News #Library
Rare Diseases
Cyprium Closes Sale for Priority Review Voucher for $205 Million
30 Mar 2026 //
GLOBENEWSWIRE
Fortress Unit Cyprium Sells Rare Pediatric PRV For $205M
23 Feb 2026 //
GLOBENEWSWIRE
Fortress Biotech, Cyprium Therapeutics Announce FDA Acceptance
15 Dec 2025 //
GLOBENEWSWIRE
Fortress Bio, Cyprium Therapeutics Update NDA For CUTX-101
01 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support